Role of Mosapride in Patients With Gastroesophageal Reflux Disease
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Gastroesophageal reflux disease (GERD) is a very common disease in the Western World. In
Taiwan, this disease is increasing gradually because the investigators' eating style is
closing to Western world.
Proton pump is the main drug for patients with GERD in the past two decades. Prokinetic agent
is an important adjuvant to the therapy of GERD. This study aims to evaluate the role of
prokinetic agent in the management of GERD.